Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04208347 |
| Consolidated Lead Sponsor | Ruijin Hospital |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 580 participants (ESTIMATED) |
| Registered Start Date | 2019-12-18 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Affiliated Hospital of Hebei University | Baoding, China | Open Hospital Dossier -> |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, China | Open Hospital Dossier -> |
| Xiangya Hospital Central South University | Changsha, China | Open Hospital Dossier -> |
| Sichuan Provincial People's Hospital | Chengdu, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.